Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA

Archives of Dermatological Research

Volumn 303, Issue 5, 2011, Pages 339-350

  Zhu, Ping ^a   Yang, Chuan ^a   Chen, Li Hong ^a   Ren, Meng ^a   Lao, Guo Juan ^a   Yan, Li ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Migration; Primary keratinocytes; Proliferation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; FOCAL ADHESION KINASE; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INCUBATION TIME; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; CATTLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTEGRIN ALPHA2BETA1; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; SERUM ALBUMIN, BOVINE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; WOUND HEALING;

EID: 79959539559     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-010-1102-z     Document Type: Article

References (45)

1. Bhagavathula N, Nerusu KC, Lal A et al (2004) Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes. J Invest Dermatol 122:130-139 (Pubitemid 38114650)
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G et al (2005) The global burden of diabetic foot disease. Lancet 366:1719-1724 (Pubitemid 41587452)
3. Brem H, Sheehan P, Boulton AJ (2004) Protocol for treatment of diabetic foot ulcers. Am J Surg 187:1S-10S
4. Chebassier N, El Houssein O, Viegas I et al (2004) In vitro induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in keratinocytes by boron and manganese. Exp Dermatol 13:484-490
5. Chen Q, Dong L, Wang L et al (2009) Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase akt and cyclooxygenase-2. Biochem Biophys Res Commun 381:192-197
6. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366:1736-1743
7. Gawlowski T, Stratmann B, Stirban AO et al (2007) Ages and methylglyoxal induce apoptosis and expression of mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res 121:117-126 (Pubitemid 350025999)
8. Golubovskaya VM, Kweh FA, Cance WG (2009) Focal adhesion kinase and cancer. Histol Histopathol 24:503-510
9. Hattori N, Mochizuki S, Kishi K et al (2009) Mmp-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol 175:533-546
10. Jeffcoate W, Bakker K (2005) World diabetes day: footing the bill. Lancet 365:1527 (Pubitemid 40615394)
11. Kim LT, Wu J, Bier-Laning C et al (2000) Focal adhesion kinase up-regulation and signaling in activated keratinocytes. J Surg Res 91:65-69 (Pubitemid 30340898)
12. Kyriakides TR, Wulsin D, Skokos EA et al (2009) Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol 28:65-73
13. Li J, Chen J, Kirsner R (2007) Pathophysiology of acute wound healing. Clin Dermatol 25:9-18 (Pubitemid 46177460)
14. Liu Y, Liang C, Liu X et al (2010) Ages increased migration and inflammatory responses of adventitial fibroblasts via rage, mapk and nf-kappab pathways. Atherosclerosis 208:34-42
15. Lobmann R, Schultz G, Lehnert H (2005) Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 28:461-471 (Pubitemid 40170965)
16. Lohwasser C, Neureiter D, Weigle B et al (2006) The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 126:291-299 (Pubitemid 43323163)
17. Mirastschijski U, Schnabel R, Claes J et al (2010) Matrix metalloproteinase inhibition delays wound healing and blocks the latent transforming growth factor-β1-promoted myofibroblast formation and function. Wound Repair Regen 18:223-234
18. Morita K, Urabe K, Moroi Y et al (2005) Migration of keratinocytes is impaired on glycated collagen I. Wound Repair Regen 13:93-101 (Pubitemid 40250434)
19. Nah SS, Choi IY, Yoo B et al (2007) Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and tnf-alpha in human osteoarthritic chondrocytes. FEBS Lett 581:1928-1932 (Pubitemid 46628804)
20. Navaratna D, McGuire PG, Menicucci G et al (2007) Proteolytic degradation of ve-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56:2380-2387 (Pubitemid 47358245)
21. O'Toole EA (2001) Extracellular matrix and keratinocyte migration. Clin Exp Dermatol 26:525-530
22. O'Toole EA, van Koningsveld R, Chen M et al (2008) Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase c pathway. J Cell Physiol 214:47-55 (Pubitemid 350220058)
23. Peppa M, Brem H, Ehrlich P et al (2003) Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 52:2805-2813 (Pubitemid 37339711)
24. Raja, Sivamani K, Garcia MS et al. (2007) Wound re-epithelialization: Modulating keratinocyte migration in wound healing. Front Biosci 12:2849-2868
25. Reiss MJ, Han YP, Garcia E et al (2010) Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery 147:295-302
26. Santoro MM, Gaudino G (2005) Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 304:274-286 (Pubitemid 40222094)
27. Scott KA, Arnott CH, Robinson SC et al (2004) Tnf-alpha regulates epithelial expression of mmp-9 and integrin alphavbeta6 during tumour promotion. A role for tnf-alpha in keratinocyte migration? Oncogene 23:6954-6966
28. Sieg DJ, Hauck CR, Schlaepfer DD (1999) Required role of focal adhesion kinase (fak) for integrin-stimulated cell migration. J Cell Sci 112(Pt 16):2677-2691 (Pubitemid 29429791)
29. Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217-228 (Pubitemid 40095873)
30. Singh R, Barden A, Mori T et al (2001) Advanced glycation end-products: a review. Diabetologia 44:129-146 (Pubitemid 32156196)
31. Sohn H, Kim YS, Kim HT et al (2006) Ganglioside gm3 is involved in neuronal cell death. FASEB J 20:1248-1250
32. Teixeira AS, Caliari MV, Rocha OA et al (1999) Aminoguanidine prevents impaired healing and deficient angiogenesis in diabetic rats. Inflammation 23:569-581 (Pubitemid 29519433)
33. Thompson CC, Ashcroft FJ, Patel S et al (2007) Pancreatic cancer cells overexpress gelsolin family capping proteins, which contribute to their cell motility. Gut 56:95-106 (Pubitemid 46044895)
34. Thornalley PJ (1998) Cell activation by glycated proteins. Age receptors, receptor recognition factors and functional classification of ages. Cell Mol Biol (Noisy-le-grand) 44:1013-1023
35. Tokumaru S, Sayama K, Shirakata Y et al (2005) Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide ll-37. J Immunol 175:4662-4668 (Pubitemid 41362007)
36. Valencia JV, Weldon SC, Quinn D et al (2004) Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Anal Biochem 324:68-78 (Pubitemid 37491125)
37. Watson A, Morris VL, Chan BM (2009) Coordinated integrin and growth factor regulation of primary keratinocyte migration mediated through extracellular signal regulated kinase and phosphoinositide 3-kinase. Arch Dermatol Res 301:307-317
38. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-870 (Pubitemid 36828927)
39. Xu H, Shen J, Liu H et al (2006) Morroniside and loganin extracted from cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress. Can J Physiol Pharmacol 84:1267-1273 (Pubitemid 46707375)
40. Yang C, Zhu P, Yan L et al (2009) Dynamic changes in matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 levels during wound healing in diabetic rats. J Am Podiatr Med Assoc 99:489-496
41. Yang W, Lu J, Weng J et al (2010) Prevalence of diabetes among men and women in china. N Engl J Med 362:1090-1101
42. Yoon SJ, Yoon YW, Lee BK et al (2009) Potential role of hmg coa reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy. Exp Mol Med 41:802-811
43. Yurko MA, O'Toole EA, Woodley DT (2001) Phosphorylation of focal adhesion kinase [pp125(fak)] is increased in human keratinocytes induced to migrate by extracellular matrices. J Cell Physiol 188:24-32 (Pubitemid 32476493)
44. Zhang F, Kent KC, Yamanouchi D et al (2009) Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Surg 250:416-423
45. Zhang ZG, Bothe I, Hirche F et al (2006) Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: Contribution of a2b1 integrin. J Cell Sci 119:1886-1895 (Pubitemid 43820857)